8-K: Mangoceuticals Engages Greentree Financial for Compliance and Issues Shares, Secures $159,950 in Equity Sale

Mangoceuticals, Inc. entered into a service agreement with Greentree Financial Group, Inc. for compliance services, issuing 40,000 shares and agreeing to pay $40,000, and also sold 75,000 shares for $159,950 through an existing equity purchase agreement.

Summary

• Mangoceuticals, Inc. has entered into a service agreement with Greentree Financial Group, Inc. for accounting and compliance services.
• Greentree will assist with compliance filings for the quarters ending March 31, 2025, June 30, 2025, September 30, 2025, and the year ending December 31, 2024.
• Greentree will also review financial documents, provide consulting services, and prepare tax returns for 2024.
• Mangoceuticals will issue 40,000 shares of restricted common stock to Greentree and pay $40,000 in cash.
• The cash payment is split into two installments: $20,000 by December 31, 2024, and $20,000 by March 31, 2025.
• The service agreement is effective until October 15, 2025, but can be terminated with 45 days' notice, with full payment due upon early termination.
• Mangoceuticals also sold 75,000 shares of common stock for $159,950 through an equity purchase agreement with Platinum Point Capital.
• The sale was executed at $2.50 per share, net of fees, discounts, and expenses.

Sentiment

Score: 6

Explanation: The document reflects standard business operations, including engaging a service provider and raising capital. While there are some dilutive effects, the actions are necessary for the company's operations and compliance.

Positives

• The engagement of Greentree Financial should ensure compliance with accounting standards and SEC regulations.
• The equity sale provides Mangoceuticals with $159,950 in capital.
• The service agreement with Greentree includes a clear scope of work and payment terms.
• The company has secured a service provider to assist with compliance filings for the next year.

Negatives

• The company is issuing 40,000 shares of restricted stock to Greentree, which could dilute existing shareholders.
• The company is paying $40,000 in cash to Greentree, which could impact cash flow.
• Early termination of the Greentree agreement requires immediate payment of the full service fee.
• The company sold shares at $2.50 per share, which may be below the market price.

Risks

• The company is reliant on Greentree for compliance and accounting services, and any issues with Greentree could impact the company.
• The company may face challenges in meeting its financial obligations to Greentree if it terminates the agreement early.
• The sale of shares to Platinum Point Capital could dilute existing shareholders.
• The company is subject to market risk and the share price could fluctuate.

Future Outlook

The company will continue to work with Greentree Financial for compliance and accounting services through October 15, 2025. The company may continue to utilize the Equity Purchase Agreement with Platinum Point Capital for future capital raises.

Management Comments

• The company has entered into a service agreement with Greentree Financial Group, Inc. to assist with compliance filings and other financial matters.
• The company has sold 75,000 shares of common stock to Platinum Point Capital for $159,950.

Industry Context

The engagement of a financial services firm for compliance is a common practice for publicly traded companies, especially those in the emerging growth phase. The use of equity purchase agreements for capital raising is also a common practice for companies seeking to raise capital quickly.

Comparison to Industry Standards

• The terms of the service agreement with Greentree are typical for such engagements, including a mix of cash and equity compensation.
• The equity purchase agreement with Platinum Point Capital is similar to other agreements of this type, with a discount to market price for the shares sold.
• The company's reliance on external firms for compliance and accounting is common for smaller public companies.

Related Party Transactions

• Eugene M. Johnston, the company's Chief Financial Officer, has served as Audit Manager for Greentree since February 2015.

Stakeholder Impact

• Shareholders may experience dilution due to the issuance of new shares.
• The company's engagement of Greentree should ensure compliance with accounting standards and SEC regulations, which is beneficial for all stakeholders.
• The capital raise provides the company with additional funds for operations and growth.

Next Steps

• Greentree Financial will begin providing compliance and accounting services to Mangoceuticals.
• Mangoceuticals will make cash payments to Greentree on December 31, 2024 and March 31, 2025.
• Mangoceuticals may continue to utilize the Equity Purchase Agreement with Platinum Point Capital for future capital raises.

Key Dates

Keywords

compliance, financial services, equity sale, service agreement, restricted stock, accounting, SEC filings, capital raise, Greentree Financial, Mangoceuticals